Overview
HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease
Status:
Completed
Completed
Trial end date:
2011-01-01
2011-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate heart rate lowering efficacy and respiratory safety of ivabradine in patients with asthma and COPD.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Medical University of Lodz
Medical Universtity of Lodz
Criteria
Inclusion Criteria:- documented diagnosis of asthma or COPD in accordance with guidelines
- stable condition, defined as a disease without exacerbation for at least 1 month prior
to study enrolment
- mean HR in holter ECG recording of ≥ 60 bpm
Exclusion Criteria:
- disease exacerbation in previous month
- inability to understand instructions on study procedures